Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 26, 1997

View Archived Issues

New aldosterone antagonists from Yamanouchi

FDA approves expansion of Sunrise Technologies' hyperopia study

CAT's anti-TGF-beta2 antibody approved for phase I/IIa trials

Protein Design Labs: Q2 1997 highlights

Cephalon awarded patents for IGF-1

Cel-Sci reaches supply agreement with American Red Cross

R.P. Scherer sells ophthalmic delivery system to Pharmacia & Upjohn

Molecular Dynamics and Amersham announce microarray technology agreement with Chiron

ADAC's coincidence detection technology in lung cancer diagnosis

Visible Genetics licenses Roche's PCR for diagnostic use

RS(3) Discovery installed at Wyeth-Ayerst

Vion and Yale amend key license agreements

Patent awarded to Fonar for MRI-guided surgery

NIH grant goes to Gryphon for protein synthesis technology

Receptor Biology clones chemokine receptor

Natural products offer relief for BPH sufferers

Targeted Genetics receives patent protection for tgDCC-E1A

Actiq scheduled for FDA advisory committee review

Antineoplastic peptides from BASF

Alcon reports new agents for controlling IOP

TNF-alpha inhibitors for septic shock and other inflammatory diseases

AEterna increases clinical programs

Medtronic: Q1 fiscal 1997 highlights

MMP inhibitors effective in rat model of arthritis

Cognition enhancer found devoid of neurotoxicity in vitro

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...